GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » IXICO PLC (LSE:IXI) » Definitions » Other Operating Expense

IXICO (LSE:IXI) Other Operating Expense : £-0.39 Mil (TTM As of Sep. 2023)


View and export this data going back to 1996. Start your Free Trial

What is IXICO Other Operating Expense?

IXICO's Other Operating Expense for the six months ended in Sep. 2023 was £-0.22 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Sep. 2023 was £-0.39 Mil.

IXICO's quarterly Other Operating Expense increased from Sep. 2022 (£-0.30 Mil) to Mar. 2023 (£-0.18 Mil) but then declined from Mar. 2023 (£-0.18 Mil) to Sep. 2023 (£-0.22 Mil).

IXICO's annual Other Operating Expense declined from Sep. 2021 (£0.04 Mil) to Sep. 2022 (£-0.69 Mil) but then increased from Sep. 2022 (£-0.69 Mil) to Sep. 2023 (£-0.39 Mil).


IXICO Other Operating Expense Historical Data

The historical data trend for IXICO's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IXICO Other Operating Expense Chart

IXICO Annual Data
Trend Sep13 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.33 -0.20 0.04 -0.69 -0.39

IXICO Semi-Annual Data
Sep13 Mar14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.27 -0.39 -0.30 -0.18 -0.22

IXICO Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Sep. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was £-0.39 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


IXICO Other Operating Expense Related Terms

Thank you for viewing the detailed overview of IXICO's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


IXICO (LSE:IXI) Business Description

Industry
Traded in Other Exchanges
Address
15 Long Lane, 4th Floor, Griffin Court, London, GBR, EC1A 9PN
IXICO PLC is a UK-based company engaged in providing clinical trial services and technology to evaluate imaging endpoints to pharmaceutical companies. Its therapeutic areas include Alzheimer's, Parkinson's, Huntington's, Multiple Sclerosis, Progressive Supranuclear Palsy, and Other Rare Neurological Diseases. Services offered by the company are Early Phase Clinical Development, Late Phase Clinical Development, Post-Marketing, and Consultancy. The company's geographical segments include the United States, Switzerland, the United Kingdom, the Netherlands, Ireland and other- Europe. The Company work with healthcare organizations across the entire clinical research journey, for drug development analytics, medical imaging operations and post-marketing surveillance.

IXICO (LSE:IXI) Headlines

No Headlines